A Phase 1, Open-label, Fixed-sequence Study To Estimate The Effects Of Multiple-dose Administration Of Itraconazole On The Steady-state Pharmacokinetics Of Pf-06649751 In Healthy Adult Subjects

Trial Profile

A Phase 1, Open-label, Fixed-sequence Study To Estimate The Effects Of Multiple-dose Administration Of Itraconazole On The Steady-state Pharmacokinetics Of Pf-06649751 In Healthy Adult Subjects

Completed
Phase of Trial: Phase I

Latest Information Update: 06 Oct 2017

At a glance

  • Drugs PF 6649751 (Primary) ; Itraconazole
  • Indications Parkinson's disease
  • Focus Pharmacokinetics
  • Sponsors Pfizer
  • Most Recent Events

    • 02 Oct 2017 Status changed from recruiting to completed.
    • 14 Aug 2017 Planned End Date changed from 10 Aug 2017 to 14 Sep 2017.
    • 14 Aug 2017 Planned primary completion date changed from 10 Aug 2017 to 14 Sep 2017.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top